Profil

Kakkos Athanasios

Département de gynécologie-obstétrique > Secteur oncologie

See author's contact details
ORCID
0000-0003-1094-1819
Main Referenced Co-authors
Goffin, Frédéric  (16)
Kridelka, Frédéric  (16)
Delbecque, Katty  (14)
De Cuypere, Marjolein  (13)
Gennigens, Christine  (13)
Main Referenced Keywords
Female (3); Humans (3); Neoplasm Staging (3); Endometrial cancer (2); endometrial carcinoma (2);
Main Referenced Disciplines
Oncology (14)
Reproductive medicine (gynecology, andrology, obstetrics) (3)
Radiology, nuclear medicine & imaging (1)

Publications (total 17)

The most downloaded
716 downloads
LAPAILLE, L., DE CUYPERE, M., GOFFIN, F., KAKKOS, A., GONNE, E., HERMESSE, J., LOVINFOSSE, P., DELBECQUE, K., THILLE, A., Kridelka, F., & GENNIGENS, C. (2021). Cancer du col utérin localement avancé : approche multidisciplinaire. Revue Médicale de Liège, 76 (5-6), 507-514. https://hdl.handle.net/2268/262897

The most cited

10 citations (Scopus®)

Daix, M., Angeles, M. A., Migliorelli, F., Kakkos, A., Martinez Gomez, C., Delbecque, K., Mery, E., Tock, S., Gabiache, E., De Cuypere, M., Goffin, F., Martinez, A., Ferron, G., & Kridelka, F. (July 2021). Concordance between preoperative ESMO-ESGO-ESTRO risk classification and final histology in early-stage endometrial cancer. Journal of Gynecologic Oncology, 32 (4), 48. doi:10.3802/jgo.2021.32.e48 https://hdl.handle.net/2268/310330

DEMARTEAU, C., PLEYERS, C., HERMESSE, J., Gennigens, C., Kakkos, A., Gonne, E., Goffin, F., & Kridelka, F. (September 2023). #749 Optimizing brachytherapy applicators implantation in locally advanced cervical cancer with transrectal ultrasound guidance. International Journal of Gynecological Cancer, 33, 91-A92. doi:10.1136/ijgc-2023-esgo.183
Peer reviewed

Streel, S.* , Salmon, A.* , DHEUR, A., Bours, V., LEROI, N., Habran, L., Delbecque, K., Goffin, F., PLEYERS, C., Kakkos, A., Gonne, E., Seidel, L., Kridelka, F.* , & Gennigens, C.*. (02 March 2023). Diagnostic Performance of Immunohistochemistry Compared to Molecular Techniques for Microsatellite Instability and p53 Mutation Detection in Endometrial Cancer. International Journal of Molecular Sciences, 24 (5), 4866. doi:10.3390/ijms24054866
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Salmon, A., Streel, S., DHEUR, A., Bours, V., Delbecque, K., Gonne, E., PLEYERS, C., De Cuypere, M., Goffin, F., Lovinfosse, P., Kakkos, A., Kridelka, F., & Gennigens, C. (February 2023). Agreement between immunohistochemistry and molecular techniques to assess microsatellite instability and p53 status in endometrial cancer [Poster presentation]. 25th BSMO Annual Meeting 2023, Hasselt, Belgium.
Peer reviewed

DHEUR, A., Salmon, A., Streel, S., Bours, V., Delbecque, K., Gonne, E., PLEYERS, C., De Cuypere, M., Goffin, F., Lovinfosse, P., Kridelka, F., Kakkos, A., & Gennigens, C. (February 2023). p53 status : a strong negative prognostic factor in endometrial carcinoma [Poster presentation]. 25th BSMO Annual Meeting 2023, Hasselt, Belgium.
Peer reviewed

Salmon, A., Dheur, A., Bours, V., Delbecque, K., Gonne, E., PLEYERS, C., De Cuypere, M., Goffin, F., Lovinfosse, P., Kridelka, F., Kakkos, A., & Gennigens, C. (October 2022). Endometrial cancer: lymphovascular space invasion is a negative prognostic factor [Poster presentation]. 23rd European Congress on Gynaecological Oncology. doi:10.1136/ijgc-2022-esgo.264
Peer reviewed

Dheur, A., Bours, V., De Cuypere, M., Delbecque, K., Gennigens, C., Goffin, F., Gonne, E., HERMESSE, J., Kridelka, F., Lovinfosse, P., PLEYERS, C., Salmon, A., & Kakkos, A. (October 2022). 2022-RA-193-ESGO Cost-effectiveness of molecular profiling for endometrial neoplasia: a single institution experience [Poster presentation]. 23rd European Congress on Gynaecological Oncology. doi:10.1136/ijgc-2022-esgo.203
Peer reviewed

DHEUR, A., Bours, V., De Cuypere, M., Delbecque, K., Gennigens, C., Goffin, F., Gonne, E., HERMESSE, J., Kakkos, A., Lovinfosse, P., PLEYERS, C., Salmon, A., & Kridelka, F. (29 September 2022). Defining prognostic risk groups amongst patients with endometrial cancer:respective role of 2009 figo stage and molecular profile [Poster presentation]. IGCS 2022, New York, United States.
Peer reviewed

Salmon, A., DHEUR, A., Bours, V., Delbecque, K., Gonne, E., PLEYERS, C., De Cuypere, M., Goffin, F., Lovinfosse, P., Kakkos, A., Kridelka, F., & Gennigens, C. (29 September 2022). Endometrial cancer: agreement between P53 immunohistochemistry and TP53 mutational analysis ? [Poster presentation]. IGCS 2022, New York, United States.
Peer reviewed

De Cuypere, M., PLEYERS, C., HERMESSE, J., Lovinfosse, P., Delbecque, K., Gonne, E., Kakkos, A., Goffin, F., Kridelka, F., & Gennigens, C. (2022). A comparison of survival and recurrence pattern of patients presenting locally advanced cervical cancer according to the histological subtype: a monocentric retrospective study [Poster presentation]. 23rd European Congress on Gynecological Oncology, Berlin, Germany.
Peer reviewed

Gennigens, C., DHEUR, A., Bours, V., Delbecque, K., Gonne, E., PLEYERS, C., Seidel, L., Streel, S., De Cuypere, M., Goffin, F., Lovinfosse, P., Kakkos, A., Kridelka, F., & Salmon, A. (2022). 2022-RA-967-ESGO Endometrial cancer: agreement between microsatellite instability in immunohistochemistry and molecular analysis ? International Journal of Gynecological Cancer. doi:10.1136/ijgc-2022-ESGO.266
Peer Reviewed verified by ORBi

Daix, M., Angeles, M. A., Migliorelli, F., Kakkos, A., Martinez Gomez, C., Delbecque, K., Mery, E., Tock, S., Gabiache, E., De Cuypere, M., Goffin, F., Martinez, A., Ferron, G., & Kridelka, F. (July 2021). Concordance between preoperative ESMO-ESGO-ESTRO risk classification and final histology in early-stage endometrial cancer. Journal of Gynecologic Oncology, 32 (4), 48. doi:10.3802/jgo.2021.32.e48
Peer Reviewed verified by ORBi

Kakkos, A., Ver Eecke, C., ONGARO, S., Traen, K., Peeters, F., Van Trappen, P., Laenen, A., Despierre, E., Van Nieuwenhuysen, E., Vergote, I., & Goffin, F. (May 2021). Robot-assisted surgery for women with endometrial cancer: Surgical and oncologic outcomes within a Belgium gynaecological oncology group cohort. European Journal of Surgical Oncology, 47 (5), 1117 - 1123. doi:10.1016/j.ejso.2020.10.005
Peer Reviewed verified by ORBi

LAPAILLE, L., DE CUYPERE, M., GOFFIN, F., KAKKOS, A., GONNE, E., HERMESSE, J., LOVINFOSSE, P., DELBECQUE, K., THILLE, A., Kridelka, F., & GENNIGENS, C. (2021). Cancer du col utérin localement avancé : approche multidisciplinaire. Revue Médicale de Liège, 76 (5-6), 507-514.
Peer reviewed

GENNIGENS, C., KRIDELKA, F., JERUSALEM, G., SEIDEL, L., GOFFIN, F., Barbeaux, A., Forget, F., KAKKOS, A., HERMESSE, J., GONNE, E., & DE CUYPERE, M. (2019). Lymphocytes count at diagnosis is a potential survival predictor in patients treated by chemoradiation in locally advanced cervical cancer [Poster presentation]. ESGO 2019 Athens: 21st European Gynaecological Oncology Congress 2019, Athens, Greece.

KAKKOS, A., GONNE, E., COIMBRA MARQUES, C., NERVO, P., REMACLE, G., THILLE, A., HAYETTE, M.-P., VAN LINTHOUT, C., KRIDELKA, F., & DELBECQUE, K. (2017). Le cas clinique du mois. Actinomycose pelvienne pseudo-tumorale : il fallait y penser. Revue Médicale de Liège, 72 (1), 10-13.
Peer reviewed

KRIDELKA, F., GOFFIN, F., Leblanc, E., DE CUYPERE, M., DOYEN, J., DELBECQUE, K., KAKKOS, A., & THILLE, A. (2015). Laparoscopy and endometrial cancer. In Minimally Invasive surgery. G Smith.

Doupagne, A., DE CUYPERE, M., KRIDELKA, F., GOFFIN, F., DELBECQUE, K., GENNIGENS, C., LAKOSI, F., KAKKOS, A., & HERMESSE, J. (September 2014). Parametrial boost does not replace optimal BT treatment in 102 patients with locally advanced cervical cancer (LACC) [Paper presentation]. ESGO, Torino, Italy.

Contact ORBi